Company intelligence / Profile preview

CALLA

Durham, North Carolina, USA

Ownership: Private
Development stage: Other

Overview

Calla Health is a medical technology company focused on improving women's health through accessible and affordable diagnostic tools. The company's flagship product, the Calla, is a portable, low-cost colposcope designed for cervical cancer screening in low-resource settings. By integrating advanced imaging with mobile technology, Calla Health enables healthcare providers to perform high-quality examinations and facilitate early detection of precancerous lesions. The company operates as a social enterprise, bridging the gap between high-end medical diagnostics and global health needs.

Therapeutic areas: Oncology
Modalities: DeviceImaging
Industry: Medical Imaging

Partnerships

Duke UniversityRice University

Beyond the preview

Go deeper on CALLA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CALLA.

Explore the full profile